Christopher Bunka, CEO, 10% Owner at Lexaria Bioscience Corp. (LXRP), bought 19,800 shares at $0.13 ($2K) on 2016-08-19, disclosed to the SEC on 2016-08-22.
Open-market purchase of $2k LXRP by CEO, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.13 | 10,500 | $1K | 53.0% |
| 2 | $0.13 | 9,300 | $1K | 47.0% |
| Total | $0.13 avg | 19,800 | $2K | 100% |
| Filing → |
| LXRP | BUY | 2016-07-15 | $7K | — | Filing → |
| LXRP | BUY | 2016-01-12 | $4K | — | Filing → |